COVID-19 vaccination starts at 3 new centres of Guwahati
COVID-19 vaccination has started at three new centres of Kamrup Metro from Friday.
The vaccination drive was started at Mahendra Mohan Choudhury Hospital (MMCH), Down Town Hospital and CRPF Composite Hospital at Amerigog, 9 Mile.
MMCH additional superintendent Dr. Anupal Kr. Sharma was the first to get vaccinated followed by Dr Mridul Das and Dr Gautam Sharma.
National Health Mission OSD Pomi Baruah and WHO representative Dr. Arup Deka monitored the drive.
At Down Town Hospital, Dr Udayan Barua, Jyotishman Dutta, Mayurakshi Dutta and Dr. Indra Kuladhipati were administered the vaccine first.
Dr. Anurag, Dr Shailendra, Dr SKL Bhagat and Dr Jitendra took the first vaccines at the CRPF hospital.
District immunization Officer Dr Bhabendra Kr Das and WHO representative Dr Bijit Gogoi monitored the drive at these two centres.
On the first day, 79 out of the targeted 100 health workers of MMCH were vaccinated while at Down Town, 100 out of 100 were administered the vaccine. At the CRPF hospital, 59 out of the targeted 100 were vaccinated on Friday.
Earlier, the vaccination drive was launched at Guwahati Medical College Hospital, Sonapur District Hospital and Marwari Hospital on January 16.
Also Read: Section 144 of CrPC imposed in parts of Central Police District in Guwahati
Assam to Conduct Dry Run of COVID-19 Vaccine on Dec 28
Centre will carry out a dry run of Covid-19 vaccination on December 28 and 29 in Assam.
Along with Assam, Gujarat, Andhra Pradesh and Punjab steps up for administration of the vaccine and assess the readiness of the planned activities.
Each state will plan it in two districts and preferably in different (five) session type settings e.g. district hospital, CHC/PHC, urban site, private health facility, rural outreach etc.
This will exercise enable end-to-end mobilisation and testing of COVID-19 vaccination process (except the vaccine) and check the usage of Co-WIN in field environment, the linkages between planning, implementation and reporting mechanisms and identify challenges and guide the way forward prior to actual implementation including improvements that may be required in the envisaged process. This will also provide a hands-on experience to programme managers at various levels.
The two-day activity will include activities from the necessary data entries in Co-WIN to vaccine receipt and allocation to deployment of team members, mock drill of session sites with test beneficiaries to reporting and evening meeting.
This will also include testing for cold storage and transportation arrangements for COVID-19 vaccine, management of crowd at the session sites with proper physical distancing.
Meanwhile, to facilitate redressal of queries on COVID-19 vaccination and Co-WIN portal related queries, the capacity of the national and sate helplines (1075 and 104) has also been strengthened to address queries.
UK Becomes 1st Country to Approve COVID-19 Vaccine for General Use
Britain on December 12 became the first country to approve Pfizer-BioNTech's Covid-19 vaccine for general use.
"The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech's Covid-19 vaccine for use," the department of health said in a statement.
"The vaccine will be made available across the UK from next week," the statement said, with priority groups including care home residents, health and care staff.
To this end, Pfizer said Britain's emergency use authorisation marks a historic moment in the fight against COVID-19.
Britain will start vaccinating people against COVID-19 with the Pfizer vaccine next week.